Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

Professional's Attitudes Do Not Influence Screening and Brief Interventions Rates for Hazardous and Harmful Drinkers: Results from ODHIN Study.

Bendtsen P, Anderson P, Wojnar M, Newbury-Birch D, Müssener U, Colom J, Karlsson N, Brzózka K, Spak F, Deluca P, Drummond C, Kaner E, Kłoda K, Mierzecki A, Okulicz-Kozaryn K, Parkinson K, Reynolds J, Ronda G, Segura L, Palacio J, Baena B, Slodownik L, van Steenkiste B, Wolstenholme A, Wallace P, Keurhorst MN, Laurant MG, Gual A.

Alcohol Alcohol. 2015 Mar 18. pii: agv020. [Epub ahead of print]

PMID:
25787012
2.

A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol.

López-Pelayo H, Wallace P, Segura L, Miquel L, Díaz E, Teixidó L, Baena B, Struzzo P, Palacio-Vieira J, Casajuana C, Colom J, Gual A.

BMJ Open. 2014 Dec 31;4(12):e007130. doi: 10.1136/bmjopen-2014-007130.

3.

Brief interventions implementation on alcohol from the European health systems perspective.

Colom J, Scafato E, Segura L, Gandin C, Struzzo P.

Front Psychiatry. 2014 Nov 11;5:161. doi: 10.3389/fpsyt.2014.00161. eCollection 2014. Review.

4.

Dobutamine-induced Intraventricular Obstruction: A "Dagger" to the Anesthetized Heart?

Fritock MD, Manento MN, Segura LG.

Anesthesiology. 2014 Jul 23. [Epub ahead of print] No abstract available.

PMID:
25057844
5.

Managing alcohol problems in general practice in Europe: results from the European ODHIN survey of general practitioners.

Anderson P, Wojnar M, Jakubczyk A, Gual A, Segura L, Sovinova H, Csemy L, Kaner E, Newbury-Birch D, Fornasin A, Struzzo P, Ronda G, van Steenkiste B, Keurhorst M, Laurant M, Ribeiro C, do Rosário F, Alves I, Scafato E, Gandin C, Kolsek M.

Alcohol Alcohol. 2014 Sep-Oct;49(5):531-9. doi: 10.1093/alcalc/agu043. Epub 2014 Jul 16.

PMID:
25031247
6.

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study.

Ballantyne CM, Hoogeveen RC, Raya JL, Cain VA, Palmer MK, Karlson BW; GRAVITY Study Investigators.

Atherosclerosis. 2014 Jan;232(1):86-93. doi: 10.1016/j.atherosclerosis.2013.10.022. Epub 2013 Nov 1.

PMID:
24401221
7.

Awake Tracheal Intubation in an 8-Year-Old Girl with McCune-Albright Syndrome.

Bohman JK, Segura L.

A A Case Rep. 2013 Oct;1(1):23-5. doi: 10.1097/ACC.0b013e318291d47e.

PMID:
25611608
8.

Images in anesthesiology: pediatric tongue injury after transesophageal echocardiography for cardiac transplantation.

Fritock MD, Segura LG, Viozzi CF.

Anesthesiology. 2014 Nov;121(5):1091. doi: 10.1097/ALN.0b013e3182a9b054. No abstract available.

PMID:
24025615
9.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

10.

Issues surrounding end-of-life decision-making.

Tejwani V, Wu Y, Serrano S, Segura L, Bannon M, Qian Q.

Patient Prefer Adherence. 2013 Aug 9;7:771-5. doi: 10.2147/PPA.S48135. eCollection 2013.

11.

Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures.

Segura LG, Lorenz JD, Weingarten TN, Scavonetto F, Bojanić K, Selcen D, Sprung J.

Paediatr Anaesth. 2013 Sep;23(9):855-64. doi: 10.1111/pan.12248. Epub 2013 Aug 6.

PMID:
23919455
12.

Implementing training and support, financial reimbursement, and referral to an internet-based brief advice program to improve the early identification of hazardous and harmful alcohol consumption in primary care (ODHIN): study protocol for a cluster randomized factorial trial.

Keurhorst MN, Anderson P, Spak F, Bendtsen P, Segura L, Colom J, Reynolds J, Drummond C, Deluca P, van Steenkiste B, Mierzecki A, Kłoda K, Wallace P, Newbury-Birch D, Kaner E, Gual T, Laurant MG.

Implement Sci. 2013 Jan 24;8:11. doi: 10.1186/1748-5908-8-11.

13.

Malaria transmission after five years of vector control on Bioko Island, Equatorial Guinea.

Overgaard HJ, Reddy VP, Abaga S, Matias A, Reddy MR, Kulkarni V, Schwabe C, Segura L, Kleinschmidt I, Slotman MA.

Parasit Vectors. 2012 Nov 12;5:253. doi: 10.1186/1756-3305-5-253.

14.

Good practices for the prevention of alcohol harmful use amongst the elderly in Europe, the VINTAGE project.

Palacio-Vieira J, Segura L, Gual A, Colom J, Ahlström S, Radoš Krnel S, McNeill A, Sovinova H, Scafato E; VINTAGE project Working Group.

Ann Ist Super Sanita. 2012;48(3):248-55.

15.

Alcohol and older people from a public health perspective.

Anderson P, Scafato E, Galluzzo L; VINTAGE project Working Group.

Ann Ist Super Sanita. 2012;48(3):232-47.

16.

Alcohol and older people. The European project VINTAGE: good health into older age. Design, methods and major results.

Galluzzo L, Scafato E, Martire S, Anderson P, Colom J, Segura L, McNeill A, Sovinova H, Rados Krnel S, Ahlström S; VINTAGE project Working Group.

Ann Ist Super Sanita. 2012;48(3):221-31.

17.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
18.

Retrograde intubation during laryngeal cleft repair on cardiopulmonary bypass.

Collard V, Segura LG, Daaboul DG, Yuki K.

J Anesth. 2012 Apr;26(2):273-4. doi: 10.1007/s00540-011-1310-5.

PMID:
22302106
19.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

20.

Absence of Thy-1 results in TGF-β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts.

Ramírez G, Hagood JS, Sanders Y, Ramírez R, Becerril C, Segura L, Barrera L, Selman M, Pardo A.

Lab Invest. 2011 Aug;91(8):1206-18. doi: 10.1038/labinvest.2011.80. Epub 2011 May 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk